Re: Predictors of infectious complications after targeted prophylaxis for prostate needle biopsy
File(s)
Accepted version
Author(s)
Miah, Saiful
Winkler, Mathias
Ahmed, Hashim U
Type
Journal Article
Abstract
Papagiannopoulos D, Abern M, Wilson N, et alJ Urol 2018;199:155–60Experts’ summary:Papagiannopoulos et al [1] are to be congratulated on their reporting of over 5000 men undergoing transrectal ultrasound-guided (TRUS) prostate biopsy with targeted antimicrobial prophylaxis with preprocedure rectal swab cultures. This method led to an overall infectious complication rate of 1.1%, whilst it was 3.9% for those harbouring a fluoroquinolone-resistant organism (odds ratio 9.98). Their article concluded that one should consider using alternative biopsy approaches to minimise infectious complications in this higher-risk cohort who harbour fluoroquinolone resistance.
Date Issued
2018-10-01
Date Acceptance
2018-04-07
Citation
European Urology, 2018, 74 (4), pp.523-524
ISSN
0302-2838
Publisher
Elsevier
Start Page
523
End Page
524
Journal / Book Title
European Urology
Volume
74
Issue
4
Copyright Statement
© 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Wellcome Trust
University College London Hospitals Charity
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/29691081
PII: S0302-2838(18)30274-4
Grant Number
204998/Z/16/Z
1348
Subjects
Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
1103 Clinical Sciences
Publication Status
Published
Coverage Spatial
Switzerland
Date Publish Online
2018-04-22